Keyphrases
Bangladesh
100%
Immunogenicity
100%
Pentavalent Rotavirus Vaccine
100%
Vietnam
100%
Asian Developing Countries
100%
Serum Neutralizing Antibodies
100%
Neutralizing Antibodies
80%
Immunoglobulin
80%
Developed Countries
60%
Anti-rotavirus
60%
Geometric Mean Titer
60%
Oral Dose
40%
Bangladeshi children
40%
Asian Countries
40%
Vietnamese
40%
Clinical Significance
20%
Placebo
20%
Immunogenic
20%
Blood Samples
20%
Placebo-controlled
20%
Group A Rotavirus
20%
Response Rate
20%
Tetanus
20%
Diphtheria
20%
Fold Increase
20%
Efficacy Trial
20%
Randomized Double-blind
20%
EPI Vaccines
20%
Seroresponse
20%
Immune Correlates of Protection
20%
First Dose
20%
Two-country
20%
Third Dose
20%
Oral Poliovirus Vaccine
20%
Vietnamese children
20%
Whole-cell Pertussis Vaccine
20%
Concomitant Use
20%
Immunology and Microbiology
Rotavirus Vaccine
100%
Immunogenicity
100%
Neutralizing Antibody
100%
Antibody Response
80%
Immunoglobulin A
80%
Rotavirus
60%
Serotype
60%
Titer
60%
Gilvetmab
40%
Human Rotavirus
20%
Whole Cell
20%
Immunity
20%
Oral Poliomyelitis Vaccine
20%
Pertussis Vaccine
20%
Pharmacology, Toxicology and Pharmaceutical Science
Rotavirus Vaccine
100%
Neutralizing Antibody
100%
Immunogenicity
100%
Immunoglobulin A
80%
Rotavirus
60%
Placebo
40%
Gilvetmab
40%
Human Rotavirus
20%
Oral Poliomyelitis Vaccine
20%
Tetanus
20%
Diphtheria
20%
Pertussis Vaccine
20%
Biochemistry, Genetics and Molecular Biology
Immunogenicity
100%
Rotavirus
100%
Neutralizing Antibody
71%
Antibody Response
57%
Immunoglobulin A
57%
Titer
42%
Serotype
42%
Whole Cell
14%
Human Rotavirus
14%
Poliomyelitis Virus
14%
Immunity
14%
Agricultural and Biological Sciences
Rotavirus
100%
Neutralizing Antibody
62%
Immunoglobulin A
50%
Serotype
37%
Titer
37%
Placebo
25%
Immunity
12%